CN Patent

CN105878242A — 包括硝基儿茶酚衍生物的药物制剂及其制备方法

Assigned to Bial Portela and Cia SA · Expires 2016-08-24 · 10y expired

What this patent protects

本发明涉及包括至少一种选自本文中定义的式I的硝基儿茶酚衍生物及其盐、酯、水合物、溶剂化物和衍生物的活性药物成分的组合物和药物制剂,以及制备所述组合物和药物制剂方法。

USPTO Abstract

本发明涉及包括至少一种选自本文中定义的式I的硝基儿茶酚衍生物及其盐、酯、水合物、溶剂化物和衍生物的活性药物成分的组合物和药物制剂,以及制备所述组合物和药物制剂方法。

Drugs covered by this patent

Patent Metadata

Patent number
CN105878242A
Jurisdiction
CN
Classification
Expires
2016-08-24
Drug substance claim
No
Drug product claim
No
Assignee
Bial Portela and Cia SA
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.